RMD vs VALU · P/E 29, rev $5.65B vs P/E 15, rev $33.4M
ResMed Inc (RMD) versus Value Line Inc (VALU) — a side-by-side from cached financials, not a winner call.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Value Line Inc (VALU) is a financial data & stock exchanges company listed on NASDAQ.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Latest reported VALU revenue for 2026-04-30 was $33.4M. Net income was $21.6M. Revenue was down 4.7% from 2025-04-30 to 2026-04-30. VALU currently screens at market cap $324.4M and trailing P/E 14.8.
RMD currently screens at market cap $37.68B and trailing P/E 28.8. VALU currently screens at market cap $324.4M and trailing P/E 14.8.
Not investment advice. Open the RMD and VALU stock pages for the full models.
Not investment advice.